Interleukin-26 Expression in Inflammatory Bowel Disease and Its Immunoregulatory Effects on Macrophages

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Apr 25

PMID 35463017

Authors

Dongjuan Song

Lijie Lai

Juntao Lu

Jinlu Tong

Zhihua Ran

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Interleukin-26 (IL-26) has been implicated in several chronic inflammatory diseases. However, its role in inflammatory bowel disease (IBD) remains to be elucidated. We aimed to investigate IL-26 expression in IBD and its immunoregulatory effects on macrophages.

Methods: We assessed IL-26 expression in the intestinal mucosa and blood samples of IBD patients and healthy controls (HC). The associations between the clinical characteristics of IBD and IL-26 expression levels in serum and peripheral blood mononuclear cells (PBMCs) were investigated. In addition, the transcriptional changes in THP-1 macrophages exposed to IL-26 were determined by RNA sequencing and validated with qRT-PCR, ELISA and western blots.

Results: Compared with HC, in IBD patients, IL-26 expression levels were elevated in the inflamed intestinal mucosa, and reduced in serum and PBMCs. IL-26 mRNA levels in PBMCs, but not serum IL-26 levels, were inversely correlated with disease activity in IBD. Furthermore, IL-26 mRNA levels in PBMCs were significantly lower in patients with complicated Crohn's disease. A total of 1,303 differentially expressed protein-coding genes were identified between untreated and IL-26-treated macrophages. The up-regulated genes showed enrichment in some inflammatory and immune-related processes and pathways. Additionally, GSEA showed that neutrophil, monocyte, and lymphocyte chemotaxis was significantly enriched in IL-26-treated macrophages. Further validation revealed that IL-26 promotes the secretion of multiple inflammatory cytokines and chemokines and upregulates the expression of adhesion molecules, MMP-8, and MMP-9 while inhibiting MMP-1 in macrophages.

Conclusion: Compared with HC, in IBD patients, IL-26 levels were elevated in the inflamed intestinal mucosa, and reduced in the peripheral blood. The transcriptional changes in macrophages exposed to IL-26 suggest that IL-26 may amplify the aberrant immune response in IBD by activating macrophages.

Citing Articles

Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes.

Hammitzsch A, Ossadnik A, Bachmann Q, Merwald-Fraenk H, Lorenz G, Witt M Front Immunol. 2024; 15:1355824.

PMID: 38799447 PMC: 11127564. DOI: 10.3389/fimmu.2024.1355824.

The role of Th17 cells in inflammatory bowel disease and the research progress.

Chen L, Ruan G, Cheng Y, Yi A, Chen D, Wei Y Front Immunol. 2023; 13:1055914.

PMID: 36700221 PMC: 9870314. DOI: 10.3389/fimmu.2022.1055914.

References

Yang W, Yu T, Huang X, Bilotta A, Xu L, Lu Y . Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020; 11(1):4457. PMC: 7478978. DOI: 10.1038/s41467-020-18262-6. View

Corvaisier M, Delneste Y, Jeanvoine H, Preisser L, Blanchard S, Garo E . IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLoS Biol. 2012; 10(9):e1001395. PMC: 3463509. DOI: 10.1371/journal.pbio.1001395. View

Britton G, Contijoch E, Mogno I, Vennaro O, Llewellyn S, Ng R . Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt Regulatory T Cells and Exacerbate Colitis in Mice. Immunity. 2019; 50(1):212-224.e4. PMC: 6512335. DOI: 10.1016/j.immuni.2018.12.015. View

Brilland B, Bach-Bunner M, Nunes Gomes C, Larochette V, Foucher E, Plaisance M . Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus. Front Immunol. 2021; 12:663192. PMC: 8160525. DOI: 10.3389/fimmu.2021.663192. View

Verstockt B, Verstockt S, Veny M, Dehairs J, Arnauts K, Van Assche G . Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019; 18(5):1142-1151.e10. PMC: 7196933. DOI: 10.1016/j.cgh.2019.08.030. View

Neurath M . Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014; 14(5):329-42. DOI: 10.1038/nri3661. View

Asano K, Takahashi N, Ushiki M, Monya M, Aihara F, Kuboki E . Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes. Nat Commun. 2015; 6:7802. PMC: 4518321. DOI: 10.1038/ncomms8802. View

Wang J, Chen W, Wang Y . The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages. Front Microbiol. 2020; 11:1065. PMC: 7296120. DOI: 10.3389/fmicb.2020.01065. View

Gong Y, Hart E, Shchurin A, Hoover-Plow J . Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest. 2008; 118(9):3012-24. PMC: 2491456. DOI: 10.1172/JCI32750. View

10.

Lin Y, Wang Y, Peng Y, Liu F, Lin G, Huang S . Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway. Cells. 2020; 9(4). PMC: 7227026. DOI: 10.3390/cells9040938. View

11.

Dang A, Teles R, Weiss D, Parvatiyar K, Sarno E, Ochoa M . IL-26 contributes to host defense against intracellular bacteria. J Clin Invest. 2019; 129(5):1926-1939. PMC: 6486355. DOI: 10.1172/JCI99550. View

12.

Bernatchez S, Atkinson M, Parks P . Expression of intercellular adhesion molecule-1 on macrophages in vitro as a marker of activation. Biomaterials. 1997; 18(20):1371-8. DOI: 10.1016/s0142-9612(97)00072-0. View

13.

Corridoni D, Antanaviciute A, Gupta T, Fawkner-Corbett D, Aulicino A, Jagielowicz M . Single-cell atlas of colonic CD8 T cells in ulcerative colitis. Nat Med. 2020; 26(9):1480-1490. DOI: 10.1038/s41591-020-1003-4. View

14.

Itoh T, Hatano R, Komiya E, Otsuka H, Narita Y, Aune T . Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis. J Invest Dermatol. 2018; 139(4):878-889. DOI: 10.1016/j.jid.2018.09.037. View

15.

Louhaichi S, Mlika M, Hamdi B, Hamzaoui K, Hamzaoui A . Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case-Control Study of Women. J Asthma Allergy. 2020; 13:95-107. PMC: 7006858. DOI: 10.2147/JAA.S229522. View

16.

Wang X, Zhang D, Fucci Q, Dollery C, Owen C . Surface-bound matrix metalloproteinase-8 on macrophages: Contributions to macrophage pericellular proteolysis and migration through tissue barriers. Physiol Rep. 2021; 9(5):e14778. PMC: 7927794. DOI: 10.14814/phy2.14778. View

17.

Maronek M, Marafini I, Gardlik R, Link R, Troncone E, Monteleone G . Metalloproteinases in Inflammatory Bowel Diseases. J Inflamm Res. 2021; 14:1029-1041. PMC: 8001665. DOI: 10.2147/JIR.S288280. View

18.

Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y . Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005; 129(3):969-84. DOI: 10.1053/j.gastro.2005.06.071. View

19.

Weiss D, Ma F, Merleev A, Maverakis E, Gilliet M, Balin S . IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells. J Immunol. 2019; 203(4):911-921. PMC: 6684376. DOI: 10.4049/jimmunol.1900318. View

20.

Wilson N, Boniface K, Chan J, McKenzie B, Blumenschein W, Mattson J . Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007; 8(9):950-7. DOI: 10.1038/ni1497. View